Concepedia

Kristel M. L. Crommentuyn

KM

Statistics

Publications

16

Citations

877

H-Index

15

Active since

2001

Affiliations

Slotervaartziekenhuis(Current)

Utrecht University

The Netherlands Cancer Institute

Emma Kinderziekenhuis

Kristel M. L. Crommentuyn is an author at Slotervaartziekenhuis specializing in pharmacokinetics, pharmacology, and antiretroviral therapy.

Publications per year

2001–2008

16

Publications

16

Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs

Maarten T. Huisman, Johan W. Smit, Kristel M. L. Crommentuyn et al. · AIDS · 2002 · 223 citations

, , +17

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients

Kristel M. L. Crommentuyn, Bregt S Kappelhoff, Jan W. Mulder et al. · British Journal of Clinical Pharmacology · 2005 · 71 citations · Full text

, , +17

Indinavir/ritonavir‐based therapy in HIV‐1‐infected antiretroviral therapy‐naive patients: comparison of 800/100 mg and 400/100 mg twice daily

Déborah Konopnicki, Bénédicte Poll, Kristel M. L. Crommentuyn et al. · HIV Medicine · 2005 · 69 citations

, , +17

The Plasma and Intracellular Steady-State Pharmacokinetics of Lopinavir/Ritonavir in HIV-1-Infected Patients

Kristel M. L. Crommentuyn, Jan W. Mulder, Albert T.A. Mairuhu et al. · Antiviral Therapy · 2004 · 63 citations · Full text

, , +14

A Pharmacokinetic and Pharmacogenetic Study of Efavirenz in Children: Dosing Guidelines can Result in Subtherapeutic Concentrations

Robter Heine, Henriëtte J. Scherpbier, Kristel M. L. Crommentuyn et al. · Antiviral Therapy · 2008 · 62 citations

, , +17

1–5 of 16